Western blot analyses revealed that trametinib treatment led to a time- and dose-dependent increase in LIFR expression and phosphorylation of STAT3 across multiple OCa cell lines (Figure 3A,B). This evidence concerns the gene LIFR and oculocutaneous albinism.